Effects of rosiglitazone on serum paraoxonase activity and metabolic parameters in patients with type 2 diabetes mellitus

Effects of rosiglitazone on serum paraoxonase activity and metabolic parameters in patients with type 2 diabetes mellitus

Show other versions (1)

Human serum paraoxonase contributes to the anti-atherogenic effect of high-density lipoprotein cholesterol (HDL-C) and has been shown to protect both low-density lipoprotein cholesterol (LDL-C) and HDL-C against lipid peroxidation. We investigated the effects of rosiglitazone on parao...

Full description

Bibliographic Details
Main Authors:	Y. Atamer, A. Atamer, A.S. Can, A. Hekimoglu, N. Ilhan, N. Yenice, Y. Kocyigit
Format:	Article
Language:	English
Published:	Associação Brasileira de Divulgação Científica 2013-06-01
Series:	Brazilian Journal of Medical and Biological Research
Subjects:	Rosiglitazone Diabetes mellitus type 2 Paraoxonase Lipoproteins Homocysteine Lipid peroxidation
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2013000600528&lng=en&tlng=en

Similar Items

Effects of rosiglitazone on serum paraoxonase activity and metabolic parameters in patients with type 2 diabetes mellitus
by: Y. Atamer, et al.
Published: (2013-01-01)

Evaluation of paraoxonase, malondialdehyde, and lipoprotein levels in patients with asymptomatic cholelithiasis
by: Aytac Atamer, et al.
Published: (2014-01-01)

Implications of serum paraoxonase activity in obesity, diabetes mellitus, and dyslipidemia
by: Sunil K Kota, et al.
Published: (2013-01-01)

Baculovirus-mediated expression and purification of human serum paraoxonase 1A
by: Robert J. Brushia, et al.
Published: (2001-06-01)

Evaluation of paraoxonase, arylesterase, and homocysteine thiolactonase activities in patients with diabetes and incipient diabetes nephropathy
by: Ayan Durmu§, et al.
Published: (2019-01-01)

The Relation of Lumbar Disc Herniation With Increased Lipid Hydroperoxide, Paraoxonase 1 and Total Oxidative Status
by: Hamza Karabag, et al.
Published: (2016-07-01)

Lipid associated antioxidants: arylesterase and paraoxonase-1 in benign prostatic hyperplasia treatment-naïve patients
by: George Awuku Asare, et al.
Published: (2018-03-01)

Homocysteine, Paraoxonase-1 and Vascular Endothelial Dysfunction: Omnibus viis Romam Pervenitur
by: Esin Eren, et al.
Published: (2014-09-01)

Long term stability of paraoxonase-1 and high-density lipoprotein in human serum
by: Beekhof Piet K, et al.
Published: (2012-05-01)

Paraoxonase 1 as an important antiatherogenic agent
by: Ewa Lidia Krzewicka-Romaniuk, et al.
Published: (2019-01-01)

Effect of Red Wine Consumption on Serum Oxidation and Adiponectin Levels in Overweight and Healthy Individuals
by: Karadeniz Muammer, et al.
Published: (2014-09-01)

Paraoxonase-1 and other factors related to oxidative stress in psoriasis
by: Magdalena Oszukowska, et al.
Published: (2020-03-01)

Serum Lipid Profiles, Relationship Between Paraoxonase/Arylesterase Activity and High-density Lipoprotein Levels in Patients with Migraine
by: Yasemin Eren, et al.
Published: (2017-09-01)

Paraoxonase 1 Phenotype and Protein N-Homocysteinylation in Patients with Rheumatoid Arthritis: Implications for Cardiovascular Disease
by: Jolanta Parada-Turska, et al.
Published: (2020-09-01)

Serum Paraoxonase Levels in Type 2 Diabetes Mellitus Patients: A Case-Control Study
by: D Namitha, et al.
Published: (2015-06-01)

Paraoxonases Activities and Polymorphisms in Elderly and Old-Age Diseases: An Overview
by: Débora Levy, et al.
Published: (2019-05-01)

Dietary effects on antioxidants, oxidised LDL and homocysteine
by: Silaste, M.-L. (Marja-Leena)
Published: (2003)

Responses Of paraoxonase 1 to dioxin-like pcb 126 ( 3,3',4,4',5-pentachlorobiphenyl): mechanisms and consequences
by: Shen, Hua
Published: (2011)

The Effect of Eicosapentaenoic Acid on the Serum Levels and Enzymatic Activity of Paraoxonase 1 in the Patients With Type 2 Diabetes Mellitus
by: Mohammad Hassan Golzari, et al.
Published: (2017-10-01)

Paraoxonase protection of LDL against peroxidation is independent of its esterase activity towards paraoxon and is unaffected by the Q→R genetic polymorphism
by: Huibi Cao, et al.
Published: (1999-01-01)

The 192R/Q polymorphs of serum paraoxonase PON1 differ in HDL binding, lipolactonase stimulation, and cholesterol effluxs⃞
by: Leonid Gaidukov, et al.
Published: (2006-11-01)

Alterations in lipid transfer to High-Density Lipoprotein (HDL) and activity of paraoxonase-1 in HIV+ patients Alterações na transferência de lípides para a lipoproteína de alta densidade (HDL) e atividade da paroxonase 1 em pacientes HIV+
by: Elaine Nunes Daminelli, et al.
Published: (2008-08-01)

European Medicines Agency (EMA) announces termination of Avandia (rosiglitazone usage in Europe)
by: Inna Igorevna Klefortova
Published: (2010-09-01)

Association of serum paraoxonase activity with lipid profile, APO-A and APO-B in subjects with different levels of HDL
by: Maryam Teimouri, et al.
Published: (2018-11-01)

Effects of Rosiglitazone on Nitrolgycerin-induced Endothelial Dysfunction
by: Perampaladas, Kumar
Published: (2010)

Effects of Rosiglitazone on Nitrolgycerin-induced Endothelial Dysfunction
by: Perampaladas, Kumar
Published: (2010)

Serum paraoxonase-3 concentration in HIV-infected patients. Evidence for a protective role against oxidation[S]
by: Gerard Aragonès, et al.
Published: (2012-01-01)

Effect of four weeks of endurance training on serum level of paraoxonase-1 and lipid profile in non-athlete obese men
by: Amouzad Mahdirejei T, et al.
Published: (2014-07-01)

Serum Paraoxonase-1-Related Variables and Lipoprotein Profile in Patients with Lung or Head and Neck Cancer: Effect of Radiotherapy
by: Elisabet Rodríguez-Tomàs, et al.
Published: (2019-07-01)

Paraoxonase 1 gene (Gln192–Arg) polymorphism and the risk of coronary artery disease in type 2 diabetes mellitus
by: Mohamed Fahmy Elnoamany, et al.
Published: (2012-06-01)

Comparison of the Efficacy of Glimepiride, Metformin, and Rosiglitazone Monotherapy in Korean Drug-Naïve Type 2 Diabetic Patients: The Practical Evidence of Antidiabetic Monotherapy Study
by: Kun Ho Yoon, et al.
Published: (2011-02-01)

Effect of hyperglycemia and rosiglitazone on renal and urinary neprilysin in db/db diabetic mice
by: Laale F. Alawi, et al.
Published: (2020-02-01)

Effects of Orange Juice and Hesperetin on Serum Paraoxonase Activity and Lipid Profile in Hyperuricemic Rats
by: Fatemeh Haidari, et al.
Published: (2012-03-01)

The correlation of paraoxonase (PON1) activity with lipid and lipoprotein levels differs with vascular disease status
by: Laura S. Rozek, et al.
Published: (2005-09-01)

The Effect of Exercise on Paraoxonase-1 Activity and Lipid Profile in Obesity and Insulin Resistance Conditions
by: Hoseyn Fatolahi, et al.
Published: (2017-06-01)

Effect of Rosiglitazone on Coronary Angiogenesis in Diabetic and Control Rats
by: Ensieh Salehi, et al.
Published: (2011-06-01)

To Study the Activity of Paraoxonase-1 and High Density Lipoprotein-Cholesterol in Alcoholic Liver Cirrhosis
by: Pooja Nemagoudar, et al.
Published: (2017-01-01)

L'extrait aqueux lyophilisé de Portulaca oleracea prévient contre la peroxydation lipidique en augmentant l'activité de la paraoxonase-1 sérique, chez des rats soumis à un régime enrichi en cholestérol [Aqueous extract of Portulaca oleracea prevents lipid peroxidation and increases serum paraoxonase-1 activity, in rats fed cholesterol enriched-diet]
by: Yahiaoui ZIDAN, et al.
Published: (2016-12-01)

Curcumin combined with metformin decreases glycemia and dyslipidemia, and increases paraoxonase activity in diabetic rats
by: Daniela Fernandes Roxo, et al.
Published: (2019-04-01)

Low Serum Paraoxonase-1 Lactonase and Arylesterase Activities in Obese Children and Adolescents
by: Sandor Raluca, et al.
Published: (2015-12-01)